Abstract: The presently disclosed subject matter relates to computer-based methods in the field of digital therapeutics by means of a digital maze. The digital mazes utilize: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.

Abstract: Provided are methods of digital therapeutics for individuals with benign connective tissue tumor. More specifically, the digital therapeutics are designed to modulate Tenosynovial Giant Cell Tumor (TGCT), on a standalone basis or by combining them with pharmaceutical drugs such as CSF1R inhibitors.

Abstract: Provided is a method of digital therapeutics for modulating one or more Parkinson's disease-related markers, symptoms, or disease progression in an individual, on a standalone basis or by combining them with medicinal agents, particularly dopaminergic agents. Also provided are corresponding systems for implementing, delivering, and adapting such therapeutic interventions.

Abstract: The presently disclosed subject matter relates to the field of digital therapeutics to decrease pro-inflammatory molecules such as cytokines and chemokines. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. The invention also provides combination therapies that comprise digital interventions together with non-digital interventions such as medicinal agents.

Abstract: The presently disclosed subject matter relates to computer-based methods in the field of digital therapeutics by means of a digital maze. The digital mazes utilize: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.

Abstract: The presently disclosed subject matter relates to the field of digital therapeutics to improve immune function. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. The invention also provides combination therapies that comprise digital interventions together with non-digital interventions such as medicinal agents.

Abstract: The presently disclosed subject matter relates to the field of digital therapeutics to improve immune function. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. The invention also provides combination therapies that comprise digital interventions together with non-digital interventions such as medicinal agents.

Abstract: The presently disclosed subject matter relates to the field of digital therapeutics to increase improve motor skills and treat movement disorders. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.

Abstract: The presently disclosed subject matter relates to the field of digital therapeutics to increase neuro-connectivity. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. The invention also provides combination therapies that comprise digital interventions together with non-digital interventions such as medicinal agents.

Abstract: The presently disclosed subject matter relates to computer-based methods in the field of digital therapeutics by means of a digital maze. The digital mazes utilize: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.

Abstract: The presently disclosed subject matter relates to the field of digital therapeutics to increase neuro-connectivity. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.

Abstract: The presently disclosed subject matter relates to the field of digital therapeutics to improve immune function. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. Various digital interventions, their related methods in digital therapeutics and systems are disclosed herein.

Abstract: Bugs in container images can be rapidly identified. For example, a computing device can receive first metadata about a first container image that includes a first version of a piece of software and second metadata about a second container image that includes a second version of the piece of software. The computing device can obtain first source code from a first location indicated in the first metadata and second source code from a second location indicated in the second metadata. The computing device can determine a difference between the first container image and the second container image by comparing the first source code to the second source code. The computing device can generate an output for display indicating the difference between the first container image and the second container image.

Abstract: Bugs in container images can be rapidly identified. For example, a computing device can receive first metadata about a first container image that includes a first version of a piece of software and second metadata about a second container image that includes a second version of the piece of software. The computing device can obtain first source code from a first location indicated in the first metadata and second source code from a second location indicated in the second metadata. The computing device can determine a difference between the first container image and the second container image by comparing the first source code to the second source code. The computing device can generate an output for display indicating the difference between the first container image and the second container image.